Sialyltransferases with enhanced legionaminic acid transferase activity for the preparation of analogs of sialoglycoconjugates

Watson, DC; Wakarchuk, WW; Leclerc, S; Schur, MJ; Schoenhofen, IC; Young, NM; Gilbert, M

HERO ID

2902129

Reference Type

Journal Article

Year

2015

Language

English

PMID

25840968

HERO ID 2902129
In Press No
Year 2015
Title Sialyltransferases with enhanced legionaminic acid transferase activity for the preparation of analogs of sialoglycoconjugates
Authors Watson, DC; Wakarchuk, WW; Leclerc, S; Schur, MJ; Schoenhofen, IC; Young, NM; Gilbert, M
Journal Glycobiology
Volume 25
Issue 7
Page Numbers 767-773
Abstract Legionaminic acids (Leg) are bacterial analogs of neuraminic acid, with the same stereochemistry but different substituents at C5, C7 and C9. Hence they may be incorporated into useful analogs of sialoglycoconjugates, and we previously reported two sialyltransferases that could utilize cytidine monophosphate (CMP)-Leg5Ac7Ac for preparation of Leg glycoconjugates, which were resistant to sialidases [Watson DC, Leclerc S, Wakarchuk WW, Young NM. 2011. Enzymatic synthesis and properties of glycoconjugates with legionaminic acid as a replacement for neuraminic acid. Glycobiology. 21:99-108.]. These were the porcine ST3Gal1 and Pasteurella multocida sialyltransferases. We now report two additional sialyltransferases with superior Leg-transferase properties to the previous two. These are (i) a truncated form of a Photobacterium α2,6-sialyltransferase with an Ala-Met mutation in its active site, and (ii) an α2,3-sialyltransferase from Neisseria meningitidis MC58 with a higher transferase activity than the P. multocida enzyme, with either CMP-Neu5Ac or CMP-Leg5Ac7Ac as the donor. These enzymes will enable the production of useful Leg5Ac7Ac glycoconjugate derivatives with either α2,6 or α2,3 linkages and unique biological properties.
Doi 10.1093/glycob/cwv017
Pmid 25840968
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English